Whether you are a good candidate for a GLP-1 (Glucagon-like peptide 1) weight-loss program depends on your health profile, medical history, lifestyle, body mass index (BMI), and other factors
At eight years, the cumulative incidence of the primary endpoint was 21.7% (95% CI, 12.2-30.6) in the surgical group and 45.1% (95% CI, 27.7-58.4) in the nonsurgical group (adjusted HR [aHR], 0.40
Also of Note: Side Effects May Be More Difficult With Age Semaglutide injections can be challenging at any age, but it's worth noting that those who are 65 years and above report a higher incidence of gastrointestinal side effects, with 86% experiencing discomfort compared to younger patients
Indeed, a U-shaped relationship links iodine status to thyroid disorders, as both deficiency and excess can be detrimental (Fig